Endocrinology, Diabetes & Metabolism Doctors in Ft Washington, PA Accepting Medicare

1 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 1

Paige Fortinsky Meizlik, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 515 Pennsylvania Ave, Ft Washington, PA 19034 Phone: 215-707-4600    Fax: 215-707-5599

News Archive

FDA clears LENSAR Laser System to perform corneal, arcuate incisions during cataract surgery

LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration for the execution of arcuate incisions during cataract surgery.

Scientists identify defects in colossal heart protein which leads to stroke, heart failure

The landmark discovery of a tiny defect in a vital heart protein has for the first time enabled heart specialists to accurately pinpoint a therapeutic target for future efforts in developing a drug-based cure for cardiovascular diseases.

Equinox Surgical Solutions introduces SutureAssist device for streamlining suture management procedures

Equinox Surgical Solutions LLC today announced the launch of their new product, SutureAssist®, designed and developed by a minimally invasive, Board Certified, OB/GYN surgeon Dr. Warren Volker M.D., Ph.D. and his team to improve patient and surgical team safety. This proprietary device lets surgeons and scrub techs acquire, hand-off, dispose of and reload sutures with an efficient, one-handed motion resulting in significantly quicker wound closure and mitigation of both needle-stick risk to the surgical team and post-op needle management liability exposure.

Senate Committee approves bill to fund State Department global health programs, global fund

The Senate Appropriations Committee on Thursday voted 29-1 to pass a $48.69 billion draft bill to "fund the State Department and foreign affairs activities in fiscal 2010," CQ reports. "Global health programs would receive $7.8 billion, which is $434 million more than fiscal 2009 funding and $178 million more than the administration request.

Positive interim results from Helix BioPharma's Topical Interferon Alpha-2b Phase II pharmacokinetic study

Helix BioPharma Corp. today announced that the first ten patients that have been enrolled in its Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions have completed the pharmacokinetic primary endpoint analyses with positive findings.

Read more Medical News

› Verified 9 days ago